Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo‐controlled study
- 2007-03-22
- RCT
- Acta Paediatrica 96(4)
- Gladys Villarruel
- Daniel Rubio
- F. Lopez
- Julio Cintioni
- Rubén Gurevech
- G. Romero
- Y. Vandenplas
- PubMed: 17306006
- DOI: 10.1111/j.1651-2227.2007.00191.x
- High evidence
- Highly Cited
The risk of having diarrhoea lasting more than 7 days was lower in the S. boulardii group (3/44 versus 12/44; RR 0.25; 95% CI 0.1-0.8).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- administered for 6 days (dose not specified in abstract)